Finanzen von PAVmed Inc (PAVM)PAVMPAVmed Inc

Evaluating the bottom line, PAVmed Inc maintains a gross margin of -269.70%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -21278.79%, while the net margin is -19993.94%. These profitability ratios, combined with a Return on Equity (ROE) of -93.42%, provide a clear picture of how effectively PAVM converts its operational activities into shareholder value.

In the context of the broader market, PAVM competes directly with industry leaders such as MDXH and AIFF. With a market capitalization of $12.60M, it holds a significant position in the sector. When comparing efficiency, PAVM's gross margin of -269.70% stands against MDXH's N/A and AIFF's 49.22%. Such benchmarking helps identify whether PAVmed Inc is trading at a premium or discount relative to its financial performance.

PAVmed has shown a mixed financial performance with a net loss of $6.6 million in Q2 2026, although this is an improvement from the previous year's loss. The gross margin remains negative, indicating ongoing challenges in profitability.